"Even in states with protective laws, the specter of federal funding threats and institutional caution can abruptly halt essential gender-affirming medical care for transgender youth, forcing families to navigate a complex and often precarious landscape."
The journey for transgender youth seeking medical affirmation can be fraught with challenges, even in regions considered politically progressive. This article delves into the experiences of families in Massachusetts who, despite moving to a state with explicit legal protections for gender-affirming care, encountered significant obstacles when a major healthcare provider abruptly ceased offering these vital treatments to minors. The decision, seemingly driven by federal funding anxieties, highlights the far-reaching impact of national political climates on local healthcare access and the profound emotional and logistical toll on young people and their families.
In late 2024, a sixth-grader, known by the nickname Bug, came home from school with a significant announcement: he identified as a boy and would be using he/him pronouns. His mother, J, who requested anonymity due to fears of harassment, responded with immediate acceptance. "OK, cool," she recalled saying, followed by the crucial question, "What do you need to be supported?" Bug’s request was direct: he needed access to healthcare.
This moment was one J had anticipated since the family’s relocation earlier that year from Texas to Massachusetts, a move motivated by the latter state’s more liberal and inclusive political landscape. While confident they could find suitable medical experts, J hadn’t foreseen that access to gender-affirming treatment could become elusive, even with supportive state laws and leadership.
Across the United States, individual hospitals, irrespective of their state’s political leaning, have independently chosen to discontinue gender-affirming care for minors. This trend appears to be a direct response to sustained political pressure and threats from the federal government targeting transgender healthcare. Reports indicate that in the initial months of a particular administration, at least 20 hospitals rescinded or restricted such services for minors. These actions were often linked to the administration’s explicit threats to withdraw federal funding or initiate investigations for fraud or wrongful claims, a pattern that has seen a continued decline in available services since.
Bug and his younger sister were born in Austin, Texas. However, J and her husband grew increasingly concerned by a series of legislative actions in Texas, including the outlawing of abortion, the dismantling of diversity, equity, and inclusion (DEI) programs, and the curtailment of medical and civil rights for LGBTQ+ individuals. Their apprehension extended to the potential impact on the support services crucial for both their children, who are also on the autism spectrum. J expressed her fear of a "frog in the boiling water" scenario, where gradual erosion of rights goes unnoticed until it’s too late. This anxiety ultimately prompted the decision to relocate the children out of Texas.
Upon Bug’s gender disclosure, J felt a sense of relief, having landed in a state with a robust "shield" law designed to protect healthcare providers offering gender-affirming care. Furthermore, Massachusetts is among the 24 states mandating that commercial insurance, which Bug’s family possessed, cover such treatments.
Following Bug’s announcement, J’s research led her to Baystate Health, the largest hospital system in the region, based in Springfield, Massachusetts. Here, the family embarked on the multi-month process of preparing Bug to begin hormone therapy. Bug, an artistic 14-year-old with a passion for horses, cats, and filmmaking, was too old for puberty blockers but was enthusiastic about starting testosterone. He anticipated the physical changes, including voice deepening, facial hair growth, and increased muscle mass, describing the prospect as "every part of it sounds fun."
However, in February of the current year, just two weeks before Bug was scheduled to commence testosterone treatment, Baystate Health issued a surprising announcement: they would no longer provide gender-affirming medications to minors, offering only counseling services. The letter sent to affected families provided no specific explanation for the abrupt policy change.
A statement from Baystate spokesperson Heather Duggan cited the potential loss of "hundreds of millions of dollars in government reimbursement" as the primary driver for the decision. This financial concern stemmed from the federal administration’s plans, as "nearly 70 percent of Baystate Health’s patients rely on Medicaid and Medicare for coverage," the statement elaborated. For Bug, this meant the eagerly anticipated medical care was suddenly out of reach. "I felt frustrated that they would do that," he commented, articulating the disappointment felt by many. "I bet there’s tons and tons of kids who are like: ‘OK, I’m going for trans-affirming healthcare. Yay!’ And then, like, tons and tons of kids were disappointed and sad and frustrated."
J described the situation as feeling as though the ground had fallen out from beneath them. "Maybe this is naive, but I didn’t think that would happen in Massachusetts," she admitted, underscoring the shock of encountering such a barrier in a state perceived as protective.
Baystate Health’s decision places them among a growing number of providers who have opted to cease offering puberty blockers and hormone therapies, even as legal challenges to these restrictions are ongoing. In a significant development this spring, Massachusetts joined a lawsuit challenging the Department of Health and Human Services’ authority to threaten federal funding for providers offering gender-affirming care to minors. A federal judge had previously ruled such threats unlawful. Subsequently, another federal judge permitted 16 states, including Massachusetts, to proceed with a separate lawsuit against the administration concerning its efforts to criminalize gender-affirming care.
The American Academy of Pediatrics, while declining an interview, has previously stated that decisions regarding gender-affirming care should be made by young patients and their families in consultation with their doctors, emphasizing that such care should be "delivered with compassion, and offered without political interference."
One mother, identified as L, whose child previously received care at Baystate, shared a deeply personal account. Before her daughter transitioned to identify as a transgender girl, she experienced severe depression and suicidal ideation. Following the initiation of puberty blockers and estrogen at Baystate, L noted a marked improvement in her daughter’s mood and academic performance. The news of Baystate’s cessation of medical treatment left L incensed. She, along with other parents, filed civil rights complaints with the Massachusetts attorney general’s office, which did not immediately respond to a request for comment. "There’s a sense of, ‘How could you?’" L expressed, highlighting the profound emotional impact. "And there’s also the awareness of the impact just pulling care could have on a youth – from a physical health perspective but also from a mental health perspective."
Both L and J have since secured alternative care arrangements for their children. L’s family enlisted their primary care physician to manage hormone prescriptions. Bug’s family was referred to Transhealth, a private specialty clinic in Northampton, Massachusetts. This clinic has reportedly absorbed approximately 50 former Baystate patients. Jo Erwin, CEO of Transhealth, stated that the clinic had been proactively expanding its capacity in anticipation of such shifts across the state. Erwin explained that Transhealth’s reliance on significant private donations, rather than solely on Medicaid and Medicare, provides a buffer against funding threats. However, she cautioned that this doesn’t entirely alleviate the broader community’s concerns. "When you see something like that go down, people get scared that it’s ultimately going to happen to everyone," Erwin remarked, reflecting the pervasive anxiety within the LGBTQ+ community.
The landscape of gender-affirming care access remains dynamic and contested. In May, Colorado’s Supreme Court mandated that a children’s hospital in that state reinstate medical treatments for transgender youth. Conversely, in Texas, a court settlement led a children’s hospital to establish the nation’s first "detransition clinic." The federal administration has continued to exert pressure on providers, including by seeking the medical records of transgender minors.
Despite the initial setback at Baystate, Bug was able to commence testosterone treatment at the new clinic in the spring. His mother, J, reported that the treatment is progressing smoothly, with Bug having learned to administer his own injections. Nevertheless, J expressed lingering anxieties about potential future federal interference that could disrupt his care. She admitted to occasionally second-guessing their move from Texas, wondering if relocating to Canada might have offered greater long-term security.
This article is a product of a partnership involving New England Public Media, NPR, and KFF Health News.
